Low-level lead exposure and elevations in blood pressure during pregnancy

Environmental Health Perspectives

Volumn 119, Issue 5, 2011, Pages 664-669

  Wells, Ellen M ^a,b   Navas Acien, Ana ^b   Herbstman, Julie B ^c   Apelberg, Benjamin J ^b   Silbergeld, Ellen K ^b   Caldwell, Kathleen L ^d   Jones, Robert L ^d   Halden, Rolf U ^b,e   Witter, Frank R ^f   Goldman, Lynn R ^b,g  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Columbia University Mailman School of Public Health ^*  (United States)

^d NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^e ARIZONA STATE UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Benchmark dose; Blood pressure; Hypertension; Lead; Pregnancy; Risk assessment; Umbilical cord

Indexed keywords

LEAD;

ADOLESCENT; ADULT; AGE; ANEMIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONTROLLED STUDY; DELIVERY; DIASTOLIC BLOOD PRESSURE; ENVIRONMENTAL EXPOSURE; FEMALE; GEOMETRY; HOUSEHOLD; HUMAN; INCOME; LABOR; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MATERNAL HYPERTENSION; PARITY; PREGNANCY; PREPREGNANCY CARE; PRIORITY JOURNAL; RACE; SMOKING; SYSTOLIC BLOOD PRESSURE; UMBILICAL CORD BLOOD; UNITED STATES;

ADOLESCENT; ADULT; BALTIMORE; BLOOD PRESSURE; ENVIRONMENTAL EXPOSURE; FEMALE; FETAL BLOOD; HUMANS; LEAD; MARYLAND; PREGNANCY; YOUNG ADULT;

EID: 79955846817     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1002666     Document Type: Article

References (48)

1. Apelberg BJ, Goldman LR, Calafat AM, Herbstman JB, Kuklenyik Z, Heidler J, et al. 2007. Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. Environ Sci Technol 41(11):3891-3897.
2. Bernard SM. 2003. Should the Centers for Disease Control and Prevention's childhood lead poisoning intervention level be lowered? Am J Public Health 93(8):1253-1260.
3. Bernert JT Jr, Turner WE, Pirkle JL, Sosnoff CS, Akins JR, Waldrep MK, et al. 1997. Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Clin Chem 43(12):2281-2291.
4. Budtz-Jorgensen E, Keiding N, Grandjean P. 2001. Benchmark dose calculation from epidemiological data. Biometrics 57(3):698-706.
5. CDC (Centers for Disease Control and Prevention). 2007. Lead exposure among females of childbearing age-United States, 2004. MMWR Morb Mortal Wkly Rep 56(16):397-400.
6. CDC (Centers for Disease Control and Prevention). 2009. Adult blood lead epidemiology and surveillance-United States, 2005-2007. MMWR Morb Mortal Wkly Rep 58(14):365-369.
7. CDC (Centers for Disease Control and Prevention). 2010. Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, July 2010. Atlanta, GA:Centers for Disease Control and Prevention.
8. Chen XK, Yang Q, Smith G, Krewski D, Walker M, Wen SW. 2006. Environmental lead level and pregnancy-induced hypertension. Environ Res 100(3):424-430.
9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. 2003. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289(19):2560-2572.
10. Chuang HY, Schwartz J, Gonzales-Cossio T, Lugo MC, Palazuelos E, Aro A, et al. 2001. Interrelations of lead levels in bone, venous blood, and umbilical cord blood with exogenous lead exposure through maternal plasma lead in peripartum women. Environ Health Perspect 109:527-532.
11. Crump K. 2002. Critical issues in benchmark calculations from continuous data. Crit Rev Toxicol 32(3):133-153.
12. Dawson EB, Evans DR, Kelly R, Van Hook JW. 2000. Blood cell lead, calcium, and magnesium levels associated with pregnancy-induced hypertension and preeclampsia. Biol Trace Elem Res 74(2):107-116.
13. Dekkers S, de Heer C, Rennen MA. 2001. Critical effect sizes in toxicological risk assessment: a comprehensive and critical evaluation. Environ Toxicol Pharmacol 10(1-2):33-52.
14. Ettinger AS, Lamadrid-Figueroa H, Téllez-Rojo MM, Mercado-García A, Peterson KE, Schwartz J, et al. 2009. Effect of calcium supplementation on blood lead levels in pregnancy: a randomized placebo-controlled trial. Environ Health Perspect 117:26-31.
15. Garovic VD, Hayman SR. 2007. Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract 3(11):613-622.
16. Glenn BS, Stewart WF, Links JM, Todd AC, Schwartz BS. 2003. The longitudinal association of lead with blood pressure. Epidemiology 14(1):30-36.
17. Greenlund KJ, Croft JB, Mensah GA. 2004. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Int Med 164(19):2113-2118.
18. Gulson BL, Jameson CW, Mahaffey KR, Mizon KJ, Korsch MJ, Vimpani G. 1997. Pregnancy increases mobilization of lead from maternal skeleton. J Lab Clin Med 130(1):51-62.
19. Harville EW, Hertz-Picciotto I, Schramm M, Watt-Morse M, Chantala K, Osterloh J, et al. 2005. Factors influencing the difference between maternal and cord blood lead. Occup Environ Med 62(4):263-269.
20. Hense HW, Filipiak B, Kiel U. 1993. The association of blood lead and blood pressure in population surveys. Epidemiology 4(2):173-179.
21. Hu H, Shih R, Rothenberg S, Schwartz BS. 2007. The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect 115:455-462.
22. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. 2006. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med 119(2):133-141.
23. Magri J, Sammut M, Savona-Ventura C. 2003. Lead and other metals in gestational hypertension. Int J Gynaecol Obstet 83(1):29-36.
24. Meyer PA, Pivetz T, Dignam TA, Homa DM, Schoonover J, Brody D. 2003. Surveillance for elevated blood lead levels among children-United States, 1997-2001. MMWR Surveill Summ 52(10):1-21.
25. Moreira LB, Gus M, Nunes G, Goncalves CB, Martins J, Wiehe M, et al. 2009. Association between pregnancy-related hypertension and severity of hypertension. J Hum Hypertens 23(6):415-419.
26. Muntner P, Menke A, De Salvo KB, Rabito FA, Batuman V. 2005. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Int Med 165(18):2155-2161.
27. Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. 2007. Lead exposure and cardiovascular disease-a systematic review. Environ Health Perspect 115:472-482.
28. Navas-Acien A, Schwartz BS, Rothenberg SJ, Hu H, Silbergeld EK, Guallar E. 2008. Bone lead levels and blood pressure endpoints: a meta-analysis. Epidemiology 19(3):496-504.
29. Nawrot TS, Thijs L, Den Hond EM, Roels HA, Staessen JA. 2002. An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens 16(2):123-131.
30. Peters JL, Kubzansky L, McNeely E, Schwartz J, Spiro A III, Sparrow D, et al. 2007. Stress as a potential modifier of the impact of lead levels on blood pressure: the Normative Aging Study. Environ Health Perspect 115:1154-1159.
31. Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR. 1996. Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA 275(16):1233-1240.
32. Rabinowitz M, Bellinger D, Leviton A, Needleman H, Schoenbaum S. 1987. Pregnancy hypertension, blood pressure during labor, and blood lead levels. Hypertension 10(4):447-451.
33. Rothenberg SJ, Karchmer S, Schnaas L, Perroni E, Zea F, Salinas V, et al. 1996. Maternal influences on cord blood lead levels. J Expo Anal Environ Epidemiol 6(2):211-227.
34. Rothenberg SJ, Kondrashov V, Manalo M, Jiang J, Cuellar R, Garcia M, et al. 2002. Increases in hypertension and blood pressure during pregnancy with increased bone lead levels. Am J Epidemiol 156(12):1079-1087.
35. Rothenberg SJ, Manalo M, Jiang J, Cuellar R, Reyes S, Sanchez M, et al. 1999. Blood lead level and blood pressure during pregnancy in South Central Los Angeles. Arch Environ Health 54(6):382-389.
36. Sand S, Victorin K, Filipsson AF. 2008. The current state of knowledge on the use of the benchmark dose concept in risk assessment. J Appl Toxicol 28(4):405-421.
37. Solomon CG, Seely EW. 2006. Hypertension in pregnancy. Endocrinol Metab Clin North Am 35(1):157-171.
38. Sowers M, Jannausch M, Scholl T, Li W, Kemp FW, Bogden JD. 2002. Blood lead concentrations and pregnancy outcomes. Arch Environ Health 57(5):489-495.
39. Travis KZ, Pate I, Welsh ZK. 2005. The role of the benchmark dose in a regulatory context. Regul Toxicol Pharmacol 43(3):280-291.
40. U.S. EPA (U.S. Environmental Protection Agency). 2000. Benchmark Dose Technical Guidance Document (External Draft). EPA/630/R-00/001. Washington, DC:U.S. EPA.
41. U.S. EPA (U.S. Environmental Protection Agency). 2010. Renovation, Repair and Painting (RRP). Available: http://www.epa.gov/lead/pubs/renovation.htm [accessed 30 August 2010].
42. U.S. EPA (U.S. Environmental Protection Agency). 2011. Benchmark Dose Software (BMDS). Available: http://www.epa.gov/ncea/bmds/ [accessed 1 April 2011].
43. Vaziri ND. 2008. Mechanisms of lead-induced hypertension and cardiovascular disease. Am J Physiol Heart Circ Physiol 295(2):H454-H465.
44. Vigeh M, Yokoyama K, Mazaheri M, Beheshti S, Ghazizadeh S, Sakai T, et al. 2004. Relationship between increased blood lead and pregnancy hypertension in women without occupational lead exposure in Tehran, Iran. Arch Environ Health 59(2):70-75.
45. Vigeh M, Yokoyama K, Ramezanzadeh F, Dahaghin M, Sakai T, Morita Y, et al. 2006. Lead and other trace metals in preeclampsia: a case-control study in Tehran, Iran. Environ Res 100(2):268-275.
46. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. 2002. Primary prevention of hypertension: clinical and public health advisory from the National High Blood Pressure Education Program. JAMA 288(15):1882-1888.
47. Witter FR, Ten Broeck J, Fox HE. 2001. A new device for safer collection of postpartum cord blood. Int J Gynaecol Obstet 72(3):259-260.
48. Yazbeck C, Thiebaugeorges O, Moreau T, Goua V, Debotte G, Sahuquillo J, et al. 2009. Maternal blood lead levels and the risk of pregnancy-induced hypertension: the EDEN cohort study. Environ Health Perspect 117:1526-1530.